SL
VCAM-1 as a predictor biomarker in cardiovascular disease
Mayarling Francisca Troncosoa, Jafet Ortiz-Quintero, Valeria Garrido-Morenoa Fernanda Sanhueza-Olivares, Alejandra Guerrero-Moncayo, Mario Chiong, Pablo F.Castro Lorena Garcia, Luigi Gabrielli, Ramón Corbalán, LuisGarrido-Olivares and Sergio Lavandero
The Association of Ascorbic Acid, Deferoxamine and N-Acetylcysteine Improves Cardiac Fibroblast Viability and Cellular Function Associated with Tissue Repair Damaged by Simulated Ischemia/Reperfusion
Parra-Flores P.; Riquelme J.A.; Valenzuela-Bustamante P.; Leiva-Navarrete S.; Vivar R.; Cayupi-Vivanco J.; Castro E.; Espinoza-Pérez C.; Ruz-Cortés F.; Pedrozo Z.; Lavandero S.; Rodrigo R.; Diaz-Araya G.
Xbp1s-FoxO1 axis governs lipid accumulation and contractile performance in heart failure with preserved ejection fraction
Gabriele G. Schiattarella, Francisco Altamirano, Soo Young Kim, Dan Tong, Anwarul Ferdous, Hande Piristine, Subhajit Dasgupta, Xuliang Wang, Kristin M. French, Elisa Villalobos, Stephen B. Spurgin, Maayan Waldman, Nan Jiang, Herman I. May, Theodore M. Hill, Yuxuan Luo, Heesoo Yoo, Vlad G. Zaha, Sergio Lavandero, Thomas G. Gillette & Joseph a.. Hill
Down syndrome and alzheimer’s disease: Common molecular traits beyond the amyloid precursor protein
Gomez W.; Morales R.; Maracaja-Coutinho V.; Parra V.; Nassif M.